Skip to content
Peptilyze
CompoundsShopsCompareGuidesMethod
Hormonal & reproductive

Melanotan II studies

219 journal papers mention Melanotan II in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.

Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether Melanotan II is safe, effective or approved for any use.

Compare Melanotan II prices, from €17.99 →

Papers
219
213 articles, 6 reviews
Earliest paper
1994
Most papers in 2012 (15)
Open access
48%
free to read somewhere
Reviews
3%
of all papers listed

What kind of studies

Of 199 papers in PubMed that mention Melanotan II in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.

  • Randomized controlled trials1
  • Other clinical trials3
  • Meta-analyses and systematic reviews0
  • Other reviews10
  • Case reports11
  • Animal studies only137
  • Studies in humans48

Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).

Registered clinical studies

Studies on ClinicalTrials.gov that mention Melanotan II in their intervention details. A registration says a study is planned or running, not what it found.

Registered
1
Completed
0
Ongoing or planned
1
Phase 1
0
Phase 2
1
Phase 3
0
  1. Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

    NCT07437560RecruitingPhase 2started 2026-02-02

The five most recently updated studies. See all 1 on ClinicalTrials.gov. Source: ClinicalTrials.gov (U.S. National Library of Medicine). Studies are found by the compound's name, so a few may be about something else.

Papers per year

1997 to 2026, peak 15 papers in a year. The latest year may still be incomplete.

1997: 1 papers1998: 2 papers1999: 2 papers2000: 4 papers2001: 2 papers2002: 4 papers2003: 13 papers2004: 6 papers2005: 14 papers2006: 7 papers2007: 15 papers2008: 15 papers2009: 10 papers2010: 7 papers2011: 9 papers2012: 15 papers2013: 5 papers2014: 11 papers2015: 12 papers2016: 5 papers2017: 5 papers2018: 8 papers2019: 4 papers2020: 9 papers2021: 9 papers2022: 5 papers2023: 1 papers2024: 9 papers2025: 4 papers2026: 2 papers19972026

Where it is published

  1. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology14 papers
  2. Endocrinology12 papers
  3. Peptides10 papers
  4. European Journal of Pharmacology6 papers
  5. The FASEB Journal6 papers

The papers

ShowAllOpen accessReviews

Most citedName in the title

No papers in this list match the filter.

LatestName in title or abstract

  1. Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review

    V Vasylieva, Annette West, Edward Karpman · Sexual Medicine Reviews · 2026

    Review

  2. (349) Therapeutic Peptides in Sexual Medicine: A Narrative Review

    E Burchfiel, N Mills, G Saffati et al. · The Journal of Sexual Medicine · 2025

    ReviewOpen accessRead the open copy →

Each list shows up to 40 papers.See all 219 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:27 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.